Cargando…
Drug coverage in treatment of malaria and the consequences for resistance evolution - evidence from the use of sulphadoxine/pyrimethamine
BACKGROUND: It is argued that, the efficacy of anti-malarials could be prolonged through policy-mediated reductions in drug pressure, but gathering evidence of the relationship between policy, treatment practice, drug pressure and the evolution of resistance in the field is challenging. Mathematical...
Autores principales: | Malisa, Allen L, Pearce, Richard J, Abdulla, Salim, Mshinda, Hassan, Kachur, Patrick S, Bloland, Peter, Roper, Cally |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908640/ https://www.ncbi.nlm.nih.gov/pubmed/20602754 http://dx.doi.org/10.1186/1475-2875-9-190 |
Ejemplares similares
-
The genetic change in P. falciparum populations of rural Tanzania resulting from national policy on firstline malaria treatment and pilot Sulfadoxine/pyrimethamine and Artesunate combination
por: Malisa, Allen, et al.
Publicado: (2010) -
The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination
por: Malisa, Allen L, et al.
Publicado: (2011) -
Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania
por: Mbugi, Erasto V, et al.
Publicado: (2006) -
Media, Health Workers, and Policy Makers' Relationship and Their Impact on Antimalarial Policy Adoption: A Population Genetics Perspective
por: Malisa, Allen, et al.
Publicado: (2011) -
Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa
por: Okell, Lucy C., et al.
Publicado: (2017)